WeVote
Log In

Bill

Bill

S 1047

Regulates certain practices of pharmacy benefits managers and health insurance carriers.

2024-2025 Regular Session Introduced by Vin Gopal and 2 co-sponsors

New Jersey bill regulates pharmacy benefits managers' and insurers' practices to address prescription drug cost management and healthcare access concerns.

Introduced in the Senate, Referred to Senate Commerce Committee
#healthinsur #pharmaceutic
0
WeVote Research Nonpartisan
Bill Summary · S 1047

Legislative bill overview

S 1047 regulates the operational practices of Pharmacy Benefits Managers (PBMs) and health insurance carriers in New Jersey. The bill aims to establish restrictions on certain business practices these entities use when managing prescription drug benefits. Specific provisions are not detailed in the available information, but the bill represents state-level intervention in the pharmaceutical supply chain.

Why is this important

PBMs act as intermediaries between insurers, pharmacies, and patients, controlling which drugs are covered and at what cost—making them influential gatekeepers in healthcare access. Rising prescription drug costs and complaints about PBM practices (such as formulary restrictions and prior authorization requirements) have prompted regulatory scrutiny across multiple states. This bill could affect drug pricing transparency, pharmacy reimbursement rates, and patient access to medications in New Jersey.

Potential points of contention

  • Industry resistance: PBMs may argue that regulations limit their ability to negotiate drug prices and manage costs, potentially increasing insurance premiums
  • Scope ambiguity: Without detailed provisions visible, stakeholders may dispute whether regulations are sufficiently targeted or overly broad
  • Enforcement mechanisms: Questions may arise about how the state will monitor compliance and what penalties apply for violations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.